Overview

Stopping Opioid Overuse in Obstetrics To Halt Exposure Trial

Status:
Enrolling by invitation
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
As the opioid epidemic continues on, more research is needed on multi-modal approaches to decrease opioid exposure after common procedures. The aim of this study is to investigate the role of a transverses abdominis block using liposome bupivacaine suspension in reducing use of opioid medications through post-operative day 7. The study is a proposed double-blind, randomized controlled trial.
Phase:
Phase 4
Details
Lead Sponsor:
University of Missouri, Kansas City
Collaborator:
Truman Medical Center
Treatments:
Bupivacaine